NASDAQ •
Healthcare •
Medical Instruments & Supplies •
Quote as of 09/09/2026 11:29
Company Profile
IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization284.41 mln
Float43.89 mln
Earnings Date09/01/2026
EPS
0.15
Overpriced
P / E
42.80
High premium
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
1.51
Highly suspicious
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
Business Description
Founded in 2021 and headquartered in Frankfurt am Main, Germany, Anbio Biotechnology develops and sells medical testing products used to detect infectious diseases, including COVID-19 and influenza. The company offers a wide range of diagnostic tools suitable for home use, clinical settings, and laboratory environments. Its products are available across major global markets, including Europe, North America, Asia Pacific, South America, and Africa.
